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Abstract
Approximately one third of patients treated with cardiac resynchronization therapy do not 
derive any detectable benefit. In these patients, acute invasive hemodynamic evaluation can 
be  used  for  therapy  optimization.  This  report  describes  the  use  of  systematic  invasive 
hemodynamic  measurements  for  clinical  decision  making  in  a  patient  who  experienced 
severe ventricular arrhythmias and clinical deterioration following a biventricular upgrade. 
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Introduction
Cardiac resynchronization therapy (CRT) has been established as an effective treatment for 
heart  failure  patients  with  severe left  ventricular  (LV) systolic  impairment  and electrical 
dyssynchrony [1]. Unfortunately, a significant proportion of apparently suitable patients fail 
to benefit [2]. In this subset of patients, acute invasive hemodynamic evaluation can be used 
to  optimize  CRT  with  alternative  LV  pacing  sites  or  atrio-ventricular  (AV)  and  inter-
ventricular pacing delays [3,4]. We describe a patient who experienced severe ventricular 
arrhythmias  and clinical  deterioration  following upgrade to a  biventricular  (BiV) system. 
CRT was discontinued, based on the outcome of invasive hemodynamic measurements.  
Case  report                                      
A  65-year-old  male  patient  with  non-ischemic  dilated  cardiomyopathy,  left  ventricular 
ejection fraction of 20%, intra-ventricular conduction delay with a QRS duration of 148 ms, 
and NYHA class 3 was scheduled for upgrade of an implantable cardioverter defibrillator 
(ICD) to a cardiac resynchronization therapy – defibrillation (CRT-D) system. The ICD had 
previously  been  implanted  for  primary  prevention.  Echocardiography  prior  to  the  BiV 
upgrade demonstrated myocardial scarring of the LV lateral wall and showed no evidence of 
mechanical dyssynchrony. Unfavorable coronary venous anatomy required epicardial LV 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 14 (1): 32-36 (2014)
This is an open access article under the CC BY-NC-ND license.
Rad MM et al, “Left Ventricular Endocardial CRT in a Non-responder”                         33
lead placement in the lateral position via minimal lateral thoracotomy. Four weeks later, the 
patient was admitted with multiple ICD discharges due to incessant ventricular tachycardia 
(VT) (Figure 1). He was sedated and Amiodarone was initiated, whereupon VT recurrences 
were no longer observed. In the following months his clinical condition deteriorated despite 
continuation of BiV pacing. 
Figure 1: Incessant VT, 4 weeks after onset of BiV pacing
An invasive hemodynamic pacing study was performed to evaluate the hemodynamic effect 
of conventional BiV pacing and to explore whether LV endocardial pacing could effectuate 
hemodynamic improvement.  For this  purpose, a temporary pacing electrode and a RADI 
pressure wire were positioned within the LV cavity, another temporary pacing electrode was 
placed in the right atrium (Figure 2). The RADI wire allowed determination of maximal rate 
of  LV pressure  rise  (LVdP/dtmax  )  as  a  measure  of  LV function.  The  pacing  protocol 
consisted  of  a  baseline  without  ventricular  pacing  (atrial  pacing)  alternated  with  AV-
sequential BiV, LV and right ventricular (RV) pacing using the implanted system and LV 
endocardial  pacing  using  the  temporary  LV pacing  electrode.  To  exclude  hemodynamic 
variability induced by spontaneous changes in heart rate, pacing was performed at a faster 
rate  10  beats  above  intrinsic  heart  rate.  Average  LVdP/dtmax  was  measured  during  10 
seconds of pacing for each pacing configuration.
 Neither LV, RV or BiV pacing with the implanted system nor LV endocardial pacing at 
different sites improved LVdP/dtmax as compared to baseline (Figure 3).  Furthermore, the 
number of premature ventricular  complexes  (PVCs) increased upon LV stimulation.  This 
was confirmed by 24 hour Holter monitoring, which demonstrated 40,000 PVCs during BiV 
pacing  versus  4000  PVCs  when  ventricular  pacing  was  programmed  off  (Figure  4). 
Considering  the  unfavourable  hemodynamic  and  pro-arrhythmic  effects  of  LV  pacing, 
placement  of  a  permanent  endocardial  LV  lead  was  not  performed  and  the  ICD  was 
programmed to ventricular pacing off (AAI-DDD mode). Our patient was scheduled for left 
ventricular  assist  device  placement.                                 
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Figure 2: X-ray detail of the invasive hemodynamic pacing study setup. The right atrial (RA), right ventricular  
(RV) and LV epicardial (LV-Epi) lead of the implanted system are shown, together with the temporary right  
atrial  (RA-Temp) and LV endocardial  electrode (LV-Endo).  The RADI pressure wire is located in the LV 
cavity
Figure 3:  Percentage change in LVdP/dtmax during AV-sequential BiV, LV and RV only pacing using the 
implanted system and LV endocardial pacing at different sites using the temporary LV endocardial electrode 
compared to baseline (AAI pacing). Epi = Epicardial, Endo = Endocardial
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Figure 4: 24 hour Holter recordings demonstrating 40,000 PVCs during BiV pacing versus 4000 PVCs during 
ventricular  pacing  programmed  off  (AAI  mode)                                      
Discussion
Patient  selection  plays  an  important  role  in  CRT response.  According  to  the  ESC heart 
failure  guidelines  available  at  the  time  of  device  implantation,  our  patient  had  a  class  I 
indication for CRT [5]. However, based on the most recent guidelines, he may not have been 
an "ideal" candidate due to the absence of a typical left bundle-branch block [1]. This is 
supported by the outcome of the acute hemodynamic measurements.  Although a definite 
relationship between acute LVdP/dtmax increase and long term clinical response needs to be 
confirmed, our findings suggest that acute invasive hemodynamic testing could help to guide 
the  decision  on  whether  or  not  to  implant  a  CRT  device  in  cases  where  there  is  less 
consensus  for  a  clinical  benefit.                                         
The  presence  of  myocardial  scar  at  the  area  targeted  by  the  LV  lead  is  an  important 
determinant of CRT response [6]. Lead position optimization in the coronary sinus is usually 
limited by side branch anatomy. A surgical epicardial  LV lead implantation may then be 
preferred.  Our  patient  had  extensive  scarring  of  the  LV  lateral  wall  which  limited  the 
possibility of placing an epicardial LV lead outside the scar region. Recently, LV endocardial 
pacing has been suggested as a potentially better alternative to the epicardial approach [7]. 
This  method allows more liberty  in lead positioning,  which  can help to  avoid  pacing in 
infarcted  areas.  However,  the  risk  of  thrombo-embolic  complications  is  unknown  and 
requires further investigation. Although the potential of acute LVdP/dtmax measurements to 
predict  long-term  outcome  needs  to  be  confirmed,  our  findings  suggest  that  acute 
hemodynamic testing of LV endocardial pacing in a temporary setup may help to identify the 
optimal pacing site and may also prevent implantation of a potentially profitless endocardial 
LV  lead  with  a  yet  unknown  risk  of  hazardous  complications.                    
In a  small  percentage of patients,  CRT may potentiate  ventricular  tachyarrhythmias.  The 
exact  mechanisms of  proarrhythmia  remain  largely  unclear  but  our  findings  suggest  that 
pacing in the region of myocardial scar may facilitate its development. This conception is 
supported by the morphology of the VT which suggested a lateral exit site close to the LV 
epicardial pacing lead. A suggested underlying mechanism is a potential increase in local 
myocardial oxygen demand by pacing, precipitating ischemia in the peri-infarct zone and 
making  it  vulnerable  to  re-entry  [8,9].  The  currently  available  evidence  is  however  too 
limited to develop strategies for stratifying patients at risk for proarrhythmia in the setting of 
CRT.   
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Conclusion
This  case  report  illustrates  the  potential  contribution  of  acute  invasive  hemodynamic 
evaluation to clinical  decision making in CRT. Acute hemodynamic testing may also be 
considered as a step-up approach to justify implantation of a LV endocardial lead and to 
guide  lead  positioning  optimization.  Finally,  this  case  underlines  the  importance  of 
considering the possibility  of CRT related proarrhythmia,  whenever CRT treated patients 
develop  new  ventricular  tachyarrhythmia's.                             
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